⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
IPHA News
Innate Pharma S.A. ADS
Innate Pharma Reports First Quarter 2026 Business Update and Financial Results
businesswire.com
IPHA
Nouveau nombre d’actions et de droits de vote d’Innate Pharma au 16 avril 2026
businesswire.com
IPHA
Number of Shares and Voting Rights of Innate Pharma as of April 16, 2026
businesswire.com
IPHA
Nouveau nombre d’actions et de droits de vote d’Innate Pharma au 16 avril 2026
businesswire.com
IPHA
Innate Pharma Announces Conference Call and Webcast for Q1 2026 Business Update
businesswire.com
IPHA
Innate Pharma organise une conférence téléphonique et un webcast pour présenter ses résultats du premier trimestre 2026
businesswire.com
IPHA
Hot off the Press: Recent Publications from Improved Pharma and Varda Space Industries Collaboration
prnewswire.com
IPHA
Peripheral T-Cell Lymphoma Market to Witness Significant Expansion at a CAGR of 7% During the Forecast Period (2026–2036) Amid Advancing Treatment Landscape | DelveInsight
globenewswire.com
MRK
IPHA
VERU
KURA
INCY
AMGN
PFE
GILD
REGN
AZN
CRSP
BIIB
NTRA
ALLO
KYMR
ADCT
IMUX
CELC
ONON
ABBV
TDOC
BMY
IMVT
GNTX
IMPP
AUTL
Innate Pharma participera à la conférence D. Boral Capital Global Conference
businesswire.com
IPHA
Innate Pharma to Participate in the D. Boral Capital Global Conference
businesswire.com
IPHA